Treatment of sepsis and septic shock

Details Treatment of sepsis and septic shock Treatment of sepsis and septic shock

2007-08-28

2007-08-28

Jiang, Shaojia Anna (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C536S004100

Reexamination Certificate

active

10807961

ABSTRACT:
A method and composition for the treatment of humans or animals for septic shock and sepsis using a mixture of sophorolipids.

REFERENCES:
patent: 5514661 (1996-05-01), Piljac
patent: 5597573 (1997-01-01), Kamireddy et al.
patent: 5648343 (1997-07-01), Carlson
patent: 6057302 (2000-05-01), Borzeix
Kandil et al., “Sophorolipids block lethal effects of septic shock” Journal of the American College of Surgeons (Sep. 2003) vol. 197, No. 3S, pp. S40-S41.
Gorin, P.A. et al., Can. J. Chem., vol. 39, p. 846 (1961).
Davila, A.M. et al., J. Chromatogr., vol. 648, p. 139 (1993).
Tulloch, A.P. et al., Can. J. Chem., vol. 40, p. 1326 (1962).
Tulloch, A.P. et al., Can J. Chem., vol. 46, p. 3337 (1968).
Zhou, Q.-H., et al., J. Am. Oil Chem. Soc., vol. 72, p. 67 (1995).
Rau, U. et al., Biotechnol. Lett., vol. 18, p. 149 (1996).
Bisht, K.S. et al., J. Org. Chem, vol. 64, pp. 780-789 (1999).

Affiliated with

Also associated with

Rating

Treatment of sepsis and septic shock does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of sepsis and septic shock, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of sepsis and septic shock will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3855198